Off-pump implant of the Jarvik 2000 ventricular assist device through median sternotomy.
Implantation of a left ventricular assist device through a median sternotomy usually requires cardiopulmonary bypass. However, the biological response to cardiopulmonary bypass is sometimes deleterious in end-stage heart failure patients, as it may compound pre-existing coagulopathy or multiorgan dysfunction. Therefore, there are potential advantages to avoiding cardiopulmonary bypass during left ventricular assist device placement. We describe a technique for off-pump implantation of the Jarvik 2000 left ventricular assist device (Jarvik Heart Inc, New York, NY) through a median sternotomy.
Anyanwu
Ani C
AC
Department of Cardiothoracic Surgery, Mount Sinai Medical Center, New York, NY 10029, USA. anelechi.anyanwu@mountsinai.org
Fischer
Gregory W
GW
Plotkina
Irina
I
Pinney
Sean
S
Adams
David H
DH
D002311:Cardiomyopathy, Dilated / Q000175:diagnosis / Q000601:surgery*; D047549:Coronary Artery Bypass, Off-Pump; D005500:Follow-Up Studies; D016027:Heart Transplantation; D006353:Heart-Assist Devices; D006801:Humans; D008297:Male; D008875:Middle Aged; D011474:Prosthesis Design; D019919:Prosthesis Implantation; D018570:Risk Assessment; D012720:Severity of Illness Index; D013249:Sternum / Q000601:surgery*; D013908:Thoracotomy / Q000379:methods; D013997:Time Factors; D016896:Treatment Outcome; D014850:Waiting Lists